Why you shouldn't sleep on Fisher & Paykel Healthcare
Firetrail's latest podcast - Firetrail Equity Edge, has just dropped. You can listen to it on all the major podcast providers or here:
In each episode, we hear from one of Firetrail’s Portfolio Managers or Equity Analysts who gives their insight on a stock in our portfolio - giving you the Firetrail Equity Edge.
The questions are always the same:
- What is the company and what does it do to make money?
- What is the stock market missing regarding the company’s outlook?
- What is the bear case and bull case for the company's outlook?
This episode focuses on Fisher & Paykel Healthcare (ASX: FPH), a manufacturer and designer of products for use in respiratory care, acute care, and the treatment of obstructive sleep apnoea.
In this episode, Firetrail High Conviction Fund co-portfolio manager Scott Olsson joins product specialist Catie Ryan and tells us what he thinks really matters for Fisher & Paykel Healthcare’s earnings outlook, what the market is missing, and what the bull and bear case is for the company's stock price.
Fisher & Paykel Healthcare is a holding in the Firetrail Australian High Conviction Fund and the Firetrail Absolute Return Fund .
3 topics
1 stock mentioned
2 funds mentioned
2 contributors mentioned